#37 Beyond numbers: quality in ADR reporting ...

Send a text message to the show!Pharmacovigilance has traditionally focused on the patient at the receiving end of a medicine. But what happens to medicines once they leave the body? In this episode, Valentina Giunchi and Joe Mitchell unpack the emerging field of ecopharmacovigil ...  Show more

Send a text message to the show!For all its ease and speed, disproportionality analysis can be distorted by many biases, making it easy to misuse and misinterpret. Michele Fusaroli from Uppsala Monitoring Centre and Eugene van Puijenbroek from the Netherlands pharmacovigilance ce ...  Show more

Bias in the way medical research is carried out means that new medicines for diseases such as cancer – as well as the tools used to diagnose patients with some conditions – are disproportionally tested on people of European heritage. This can lead to those not represented in the ...  Show more

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode covers goals of care conversations.Our guest for this episode is Dr. Tavis Apramian, a clinician-investigator in the Department of Family & Community Medicine (DFCM) at the Universi ...  Show more

<span style="font-weight: 400;">In this episode, I have a fascinating 3-hour conversation with Dr. Jessica Rose about all things related to C-word juices, ranging from interpreting the adverse event reporting system to the future of mandatory prophylactic gene therapy. </span> ...

This is Episode 37 of PsychCrunch, the podcast of the British Psychological Society's Research Digest, sponsored by Routledge Psychology. [Content warning: This episode centres around cancer. As such, it makes references to medical events and themes that some listeners may find d ...  Show more